SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016853
Filing Date
2022-08-11
Accepted
2022-08-11 16:07:42
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vor-20220630.htm   iXBRL 10-Q 2128630
2 EX-10.1 vor-ex10_1.htm EX-10.1 90365
3 EX-31.1 vor-ex31_1.htm EX-31.1 20528
4 EX-31.2 vor-ex31_2.htm EX-31.2 20532
5 EX-32.1 vor-ex32_1.htm EX-32.1 23459
  Complete submission text file 0000950170-22-016853.txt   7585569

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vor-20220630.xsd EX-101.SCH 39734
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vor-20220630_cal.xml EX-101.CAL 40798
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vor-20220630_pre.xml EX-101.PRE 234567
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vor-20220630_def.xml EX-101.DEF 124467
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vor-20220630_lab.xml EX-101.LAB 337812
56 EXTRACTED XBRL INSTANCE DOCUMENT vor-20220630_htm.xml XML 1534375
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39979 | Film No.: 221155732
SIC: 2836 Biological Products, (No Diagnostic Substances)